Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria.

Published in:

Journal of Infectious Diseases, 1998, v. 177, n. 6, p. 1664, doi. 10.1086/515331

By:

• Ockenhouse, Christian F.;
• Sun, Pei-fang;
• Lanar, David E.;
• Wellde, Bruce T.;
• Hall, B. Ted;
• Kester, Kent;
• Stoute, Jose A.;
• Magill, Alan;
• Krzych, Urszula;
• Farley, Linda;
• Wirtz, Robert A.;
• Sadoff, Jerald C.;
• Kaslow, David C.;
• Kumar, Sanjai;
• Preston Church, L. W.;
• Crutcher, James M.;
• Wizel, Benjamin;
• Hoffman, Stephen;
• Lalvani, Ajit;
• Hill, Adrian V. S.

Publication type:

Article